9. Bibliografía

-Doronin KK, Iurov GK, Grinenko NF, Zakharchuk AN, Denisova TS, Baburina TM, Krugliak VA, Naroditskiĭ BS. Ekspressiia gena, kodiruiushchego blok kapsida VP7 rotavirusa svineĭ v sostave genoma nedefektnogo rekombinantnogo adenovirusa. Mol Gen Mikrobiol Virusol. 1995; (4):35-9.

-Isken O, Grassmann CW, Yu H, Behrens SE. Complex signals in the genomic 3′ nontranslated region of bovine viral diarrhea virus coordinate translation and replication of the viral RNA. RNA. 2004; 10(10):1637-52.

-Breitbart M, Rohwer F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol. 2005; 13(6):278-84.

-Fujimuro M. The Interactions between Cells and Viruses. Int J Mol Sci. 2024; 25(13):6886.

-Taylor NMI, Leiman PG. Editorial overview: Virus structure and expression. Curr Opin Virol. 2020; 45:iii-v).

-Simón D, Fajardo A, Moreno P, Moratorio G, Cristina J. An Evolutionary Insight into Zika Virus Strains Isolated in the Latin American Region. Viruses. 2018; 10(12):698.

-Olry de Labry-Lima A, Bermúdez-Tamayo C, Martinez-Olmos J, Martin-Ruiz E. The use of masks to protect against respiratory infections: An umbrella review. Enferm Infecc Microbiol Clin (Engl Ed). 2021; 39(9):436-444.

-Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021; 19(3):141-154.

-Koonin EV, Krupovic M, Agol VI. The Baltimore Classification of Viruses 50 Years Later: How Does It Stand in the Light of Virus Evolution? Microbiol Mol Biol Rev. 2021; 85(3):e0005321.

-Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL. Host Immune Response to Influenza A Virus Infection. Front Immunol. 2018; 9:320.

-Maarouf M, Rai KR, Goraya MU, Chen JL. Immune Ecosystem of Virus-Infected Host Tissues. Int J Mol Sci. 2018; 19(5):1379.

-Jiang H, Zhang Z. Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase. Virol J. 2023; 20(1):193.

-Laing KJ, Ouwendijk WJD, Koelle DM, Verjans GMGM. Immunobiology of Varicella-Zoster Virus Infection. J Infect Dis. 2018; 218(suppl_2):S68-S74).

-Becerril S, Corchado-Cobos R, García-Sancha N, Revelles L, Revilla D, Ugalde T, Román-Curto C, Pérez-Losada J, Cañueto J. Viruses and Skin Cancer. Int J Mol Sci. 2021; 22(10):5399.

-Knöpfel N, Noguera-Morel L, Latour I, Torrelo A. Viral exanthems in children: A great imitator. Clin Dermatol. 2019; 37(3):213-226.

-Keighley CL, Saunderson RB, Kok J, Dwyer DE. Viral exanthems. Curr Opin Infect Dis. 2015; 28(2):139-50.

-Casanova JM, Sanmartín V, Soria X, Baradad M, Martí RM, Font A. Dermatosis infantiles en la consulta de Dermatología de un hospital general universitario en España. Actas Dermosifiliogr. 2008 Mar;99(2):111-8.

-Skubic L, Hošnjak L, Breznik V, Fujs Komloš K, Luzar B, Poljak M. An Improved Protocol for Comprehensive Etiological Characterization of Skin Warts and Determining Causative Human Papillomavirus Types in 128 Histologically Confirmed Common Warts. Viruses. 2022; 14(10):2266.

-Gopinath D, Koe KH, Maharajan MK, Panda S. A Comprehensive Overview of Epidemiology, Pathogenesis and the Management of Herpes Labialis. Viruses. 2023; 15(1):225.

-Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical Manifestations and Management. Viruses 2022, 14(2):192.

-Zaborska M, Chruszcz M, Sadowski J, Klaudel T, Pelczarski M, Sztangreciak-Lehun A, Bułdak RJ. The most common skin symptoms in young adults and adults related to SARS-CoV-2 virus infection. Arch Dermatol Res. 2024; 316(6):292.

-Patruno C, Napolitano M, Genco L, Passante M, Lacarrubba F, Noto M, Fabbrocini G. Monkeypox: a dermatologist perspective. Ital J D ermatol Venerol. 2023; 158(1):21-25.

-Connolly SA, Jardetzky TS, Longnecker R. The structural basis of herpesvirus entry. Nat Rev Microbiol. 2021; 19(2):110-121.

-Campos MA, Zolini GP, Kroon EG. Impact of Toll-Like Receptors (TLRs) and TLR Signaling Proteins in Trigeminal Ganglia Impairing Herpes Simplex Virus 1 (HSV-1) Progression to Encephalitis: Insights from Mouse Models. Front Biosci (Landmark Ed). 2024; 29(3):102).

-Uyangaa E, Patil AM, Eo SK. Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virus. Immune Netw. 2014; 14(4):187-200.

-Soudja SM, Chandrabos C, Yakob E, Veenstra M, Palliser D, Lauvau G. Memory-T-cell-derived interferon-γ instructs potent innate cell activation for protective immunity. Immunity. 2014; 40(6):974-88.

-Björkström NK, Strunz B, Ljunggren HG. Natural killer cells in antiviral immunity. Nat Rev Immunol. 2022; 22(2):112-123.

-Ouwendijk WJ, Laing KJ, Verjans GM, Koelle DM. T-cell immunity to human alphaherpesviruses. Curr Opin Virol. 2013; 3(4):452-60.

-Tognarelli EI, Palomino TF, Corrales N, Bueno SM, Kalergis AM, González PA. Herpes Simplex Virus Evasion of Early Host Antiviral Responses. Front Cell Infect Microbiol. 2019; 9:127.

-Steiner I, Benninger F. Manifestations of Herpes Virus Infections in the Nervous System. Neurol Clin. 2018; 36:725-738.

-Omarova S, Cannon A, Weiss W, Bruccoleri A, Puccio J. Genital Herpes Simplex Virus-An Updated Review. Adv Pediatr. 2022; 69(1):149-162).

-Marcocci ME, Napoletani G, Protto V, Kolesova O, Piacentini R, Li Puma DD, Lomonte P, Grassi C, Palamara AT, De Chiara G. Herpes Simplex Virus-1 in the Brain: The Dark Side of a Sneaky Infection. Trends Microbiol. 2020; 28(10):808-820.

-Menendez CM, Carr DJJ. Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection. J Neuroimmunol. 2017; 308:43-49.

-Itzhaki RF. Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease. Front Aging Neurosci. 2018; 10:324.

-Gundamraj V, Hasbun R. Viral meningitis and encephalitis: an update. Curr Opin Infect Dis. 2023; 36:177-185.

-Groves MJ. Genital Herpes: A Review. Am Fam Physician. 2016; 93:928-34.

-Westhoff GL, Little SE, Caughey AB. Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. Obstet Gynecol Surv. 2011; 66:629-38.

-Pinninti SG, Kimberlin DW. Preventing herpes simplex virus in the newborn. Clin Perinatol. 2014; 41:945-55.

-Harris JB, Holmes AP. Neonatal Herpes Simplex Viral Infections and Acyclovir: An Update. J Pediatr Pharmacol Ther. 2017; 22:88-93.

-Sauerbrei A, Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 1: herpes simplex virus infections. Med Microbiol Immunol. 2007; 196:89-94.

-Hemelaar SJ, Poeran J, Steegers EA, van der Meijden WI. Neonatal herpes infections in The Netherlands in the period 2006-2011. J Matern Fetal Neonatal Med. 2015; 28:905-9.

-James C, Harfouche M, Welton NJ, Turner KM, Abu-Raddad LJ, Gottlieb SL, Looker KJ. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020; 98(5):315-329.

-Ahmad I, Wilson DW. HSV-1 Cytoplasmic Envelopment and Egress. Int J Mol Sci. 2020; 21(17):5969.

-Aslanova M, Ali R, Zito PM. Herpetic Gingivostomatitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jun 12.

-Coppola N, Cantile T, Adamo D, Canfora F, Baldares S, Riccitiello F, Musella G, Mignogna MDD, Leuci S. Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review. Clin Oral Investig. 2023; 27(11):6333-6344.

-Huang CW, Hsieh CH, Lin MR, Huang YC. Clinical features of gingivostomatitis due to primary infection of herpes simplex virus in children. MC Infect Dis. 2020; 20(1):782.

-Marchi S, Trombetta CM, Gasparini R, Temperton N, Montomoli E. Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014. J Prev Med Hyg. 2017; 58:E27-E33.

-Hamodat M. Herpes simplex / zoster. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/skinnontumorherpeszoster.html. Accessed September 15th, 2024.

-Gaspari V, Orioni G, Peron I, Misciali C, Bardazzi F. A case of guttate psoriasis after primary herpetic gingivostomatitis. Int J STD AIDS. 2024; 35(9):739-741.

-Goldman RD. Acyclovir for herpetic gingivostomatitis in children. Can Fam Physician. 2016; 62:403-4.

-Boitsaniuk S, Levkiv MО, Fedoniuk LY, Kuzniak NB, Bambuliak AV. Acute herpetic stomatitis: clinical manifestations, diagnostics and treatment strategies. Wiad Lek. 2022;75(1 pt 2):318-323.

-Leung AKC, Barankin B. Herpes Labialis: An Update. Recent Pat Inflamm Allergy Drug Discov. 2017; 11:107-113.

-Chen F, Xu H, Liu J, Cui Y, Luo X, Zhou Y, Chen Q, Jiang L. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis. J Oral Pathol Med. 2017; 46:561-568.

-Chi CC, Wang SH, Delamere FM, Wojnarowska F, Peters MC, Kanjirath PP. Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database Syst Rev. 2015;(8):CD010095.

-Magri F, Chello C, Pranteda G, Pranteda G. Erythema multiforme: Differences between HSV-1 and HSV-2 and management of the disease-A case report and mini review. Dermatol Ther. 2019; 32(3):e12847.

-Lucchese A. From HSV infection to erythema multiforme through autoimmune crossreactivity. Autoimmun Rev. 2018; 17(6):576-581.

-Soares A, Sokumbi O. Recent Updates in the Treatment of Erythema Multiforme. Medicina (Kaunas). 2021; 57(9):921.

-Orvain C, Ducancelle A, Eymerit-Morin C, Rousselet MC, Oberti F, Hunault-Berger M, Tanguy-Schmidt A. Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroids. J Clin Virol. 2015; 62:66-8.

-Rozenberg F. Virus herpes simplex et infections du système nerveux central: encéphalite, méningite, myélite. Virologie (Montrouge). 2020; 24(5):283-294.

-Van Wagoner N, Qushair F, Johnston C. Genital Herpes Infection: Progress and Problems. Infect Dis Clin North Am. 2023; 37(2):351-367.

-Hammad WAB, Konje JC. Herpes simplex virus infection in pregnancy – An update. Eur J Obstet Gynecol Reprod Biol. 2021; 259:38-45.

-Backes IM, Leib DA, Ackerman ME. Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections. Front Immunol. 2022; 13:959603.

-Pittet LF, Curtis N. Postnatal Exposure to Herpes Simplex Virus: To Treat or Not to Treat? Pediatr Infect Dis J. 2021; 40(5S):S16-S21.

-Cherpes TL, Matthews DB, Maryak SA. Neonatal herpes simplex virus infection. Clin Obstet Gynecol. 2012; 55(4):938-44.

–De Rose DU, Bompard S, Maddaloni C, Bersani I, Martini L, Santisi A, Longo D, Ronchetti MP, Dotta A, Auriti C. Neonatal herpes simplex virus infection: From the maternal infection to the child outcome. J Med Virol. 2023; 95(8):e29024.

-Samies NL, James SH, Kimberlin DW. Neonatal Herpes Simplex Virus Disease: Updates and Continued Challenges. Clin Perinatol. 2021; 48(2):263-274.

-Taylor M, Gerriets V. Acyclovir. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 May 7.

-Kennedy PGE, Mogensen TH, Cohrs RJ. Recent Issues in Varicella-Zoster Virus Latency. Viruses. 2021; 13(10):2018.

-Kennedy PGE. The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation. Viruses. 2023; 15(8):1663.

-Heininger U, Seward JF. Varicella. Lancet. 2006; 368:1365-76.

-Gershon AA, Gershon MD, Shapiro ED. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster. J Infect Dis. 2021; 224(12 Suppl 2):S387-S397.

-Spoulou V, Alain S, Gabutti G, Giaquinto C, Liese J, Martinon-Torres F, Vesikari T. Implementing Universal Varicella Vaccination in Europe: The Path Forward. Pediatr Infect Dis J. 2018. doi: 10.10979.

–Andrei G, Snoeck R. Advances and Perspectives in the Management of Varicella-Zoster Virus Infections. Molecules. 2021; 26(4):1132.

–Bertelli A, Carta V, Mangeri L, Caruso A, De Francesco MA. Varicella-Zoster Virus Prevalence among Pregnant Women: A European Epidemiological Review. Life (Basel). 2023; 13(2):593.

-Bozzola E, Spina G, Marchili MR, Brusco C, Guolo S, Rossetti C, Logrieco G, Pignatelli F, Raponi M, Villani A. Pediatric Hospitalization for Varicella in an Italian Pediatric Hospital: How Much Does It Cost? Int J Environ Res Public Health. 2021; 18(22):12053., eso sin tener en cuenta los costos indirectos (días laborales perdidos por los padres, transporte, etc).

-Kim JH, Kim JE, Bae JM. Incidences of Varicella in Children of Jeju-do, Republic of Korea, 2005-2016: Age-Period-Cohort Analysis. Epidemiol Health. 2018:e2018054.

-Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2018. doi: 10.1080/21645515.2018.1546525.

–Bardsley M, Loveridge P, Bednarska NG, Smith S, Morbey RA, Amirthalingam G, Elson WH, Bates C, de Lusignan S, Todkill D, Elliot AJ. The Epidemiology of Chickenpox in England, 2016-2022: An Observational Study Using General Practitioner Consultations. Viruses. 2023; 15(11):2163.

-Bogusz J, Paradowska-Stankiewicz I. Chickenpox in Poland in 2020. Przegl Epidemiol. 2022; 76(4):568-573.

-Widgren K, Persson Berg L, Mörner A, Lindquist L, Tegnell A, Giesecke J, Studahl M. Severe chickenpox disease and seroprevalence in Sweden – implications for general vaccination. Int J Infect Dis. 2021; 111:92-98.

-Pawaskar M, Burgess C, Pillsbury M, Wisløff T, Flem E. Clinical and economic impact of universal varicella vaccination in Norway: A modeling study. PLoS One. 2021; 16(7):e0254080.

-Levin MJ. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. J Clin Virol. 2014; 61:487-95.

-Marin M, Leung J, Lopez AS, Shepersky L, Schmid DS, Gershon AA. Communicability of varicella before rash onset: a literature review. Epidemiol Infect. 2021; 149:e131.

-Kennedy JJ, Steain M, Slobedman B, Abendroth A. Infection and functional modulation of human monocytes and macrophages by varicella zoster virus. J Virol. 2018. pii: JVI.01887-18.

-Forbes HJ, Williamson E, Benjamin L, Breuer J, Brown MM, Langan SM, Minassian C, Smeeth L, Thomas SL, Warren-Gash C. Association of herpesviruses and stroke: Systematic review and meta-analysis. PLoS One. 2018; 13:e0206163.

-Hobbelen PH, Stowe J, Amirthalingam G, Miller L, van Hoek AJ. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. J Infect. 2016; 73:241-53.

-González F, Rojas P. Is acyclovir effective for the treatment of varicella in children and adolescents? Medwave. 2018;18(6):e7269.

-Salleras L, Salleras M, Soldevila N, Prat A, Garrido P, Domínguez Á. Vacunas frente al virus varicella-zoster. Enferm Infecc Microbiol Clin. 2015; 33:411-23.

-Talbird SE, La EM, Mauskopf J, Altland A, Daniels V, Wolfson LJ. Understanding the role of exogenous boosting in modeling varicella vaccination. Expert Rev Vaccines. 2018; 17:1021-1035.

-Wen SY, Liu WL. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study. Pediatrics. 2015; 135:e565-71.

-Din S, Selinger CP, Black CJ, Ford AC. Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Aliment Pharmacol Ther. 2023; 57(6):666-675.

-Henze L, Buhl C, Sandherr M, Cornely OA, Heinz WJ, Khodamoradi Y, Kiderlen TR, Koehler P, Seidler A, Sprute R, Schmidt-Hieber M, von Lilienfeld-Toal M. Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus. Ann Hematol. 2022; 101(3):491-511.

-Gruver C, Guthmiller KB. Postherpetic Neuralgia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.2023 Apr 17.

-Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Bouza E. Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper. Rev Esp Quimioter. 2023; 36(3):223-235.

-Kowalsky DS, Wolfson AB. Corticosteroids for Preventing Post Herpetic Neuralgia after Herpes Zoster Infection. Acad Emerg Med. 2018. doi: 10.1111/acem.13661.

-Hoshino T, Toi S, Toda K, Uchiyama Y, Yoshizawa H, Iijima M, Shimizu Y, Kitagawa K. Ischemic Stroke due to Virologically-Confirmed Varicella Zoster Virus Vasculopathy: A Case Series. J Stroke Cerebrovasc Dis. 2018. pii: S1052-3057(18)30580-9.

-Valladales-Restrepo LF, Velasquez-Quimara S, Machado-Alba JE. Pharmacological Treatment of Herpes Zoster and Factors Associated with Its Recurrence. Antibiotics (Basel). 2023; 12(4):757.

-Marra Y, Lalji F. Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines. Viruses. 2022; 14(12):2667.

-Giannelos N, Ng C, Curran D. Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review. Hum Vaccin Immunother. 2023; 19(1):2168952.

-Syed YY. Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster. Drugs Aging. 2018. doi: 10.1007/s40266-018-0603-x.

-Mbinta JF, Nguyen BP, Awuni PMA, Paynter J, Simpson CR. Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis. Lancet Healthy Longev. 2022; 3(4):e263-e275.

-Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014; 371:1526-33.

-Lim DZJ, Tey HL, Salada BMA, Oon JEL, Seah ED, Chandran NS, Pan JY. Herpes Zoster and Post-Herpetic Neuralgia-Diagnosis, Treatment, and Vaccination Strategies. Pathogens. 2024; 13(7):596.

-Skubic L, Breznik V, Poljak M. Different skin wart types, different human papillomavirus types? A narrative review. Acta Dermatovenerol Alp Pannonica Adriat. 2023; 32(4):165-171.

-Hufbauer M, Akgül B. Molecular Mechanisms of Human Papillomavirus Induced Skin Carcinogenesis. Viruses. 2017; 9. pii: E187. doi: 10.3390/v9070187.

-Al Aboud AM, Nigam PK. Wart. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.2023 Aug 14.

-Touprong R, Thompson T, Williams LA. Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds. Int J Pharm Compd. 2023; 27(3):182-190.

-Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Res. 2017; 772:3-12.

-Burd EM, Dean CL. Human Papillomavirus. Microbiol Spectr. 2016;4. doi: 10.1128.

-Doorbar J. Host control of human papillomavirus infection and disease. Best Pract Res Clin Obstet Gynaecol. 2018; 47:27-41.

-Tummers B, Burg SH. High-risk human papillomavirus targets crossroads in immune signaling. Viruses. 2015; 7:2485-506.

-Groves IJ, Coleman N. Pathogenesis of human papillomavirus-associated mucosal disease. J Pathol. 2015; 235:527-38.

-Zhu P, Qi RQ, Yang Y, Huo W, Zhang Y, He L, Wang G, Xu J, Zhang F, Yang R, Tu P, Ma L, Liu Q, Li Y, Gu H, Cheng B, Chen X, Chen A, Xiao S, Jin H, Zhang J, Li S, Yao Z, Pan W, Yang H, Shen Z, Cheng H, Song P, Fu L, Chen H, Geng S, Zeng K, Wang J, Tao J, Chen Y, Wang X, Gao XH. Clinical guideline for the diagnosis and treatment of cutaneous warts (2022). J Evid Based Med. 2022; 15(3):284-301

-de Planell-Mas E, Martínez-Garriga B, Zalacain AJ, Vinuesa T, Viñas M. Human papillomaviruses genotyping in plantar warts. J Med Virol. 2017; 89:902-907.

-Bristow I. Paediatric Cutaneous Warts and Verrucae: An Update. Int J Environ Res Public Health. 2022; 19(24):16400.

-Oganesyan A, Sivesind T, Dellavalle R. From the Cochrane Library: Topical Treatments for Cutaneous Warts. JMIR Dermatol. 2021; 4(2):e33900.

-Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012; (9):CD001781.

-Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br J Dermatol. 2011; 165:233-46.

-Cengiz FP, Emiroglu N, Su O, Onsun N. Effectiveness and safety profile of 40% trichloroacetic acid and cryotherapy for plantar warts. J Dermatol. 2016; 43:1059-61.

-López López D, Vilar Fernández JM, Losa Iglesias ME, Álvarez Castro C, Romero Morales C, García Sánchez MM, Becerro de Bengoa Vallejo R. Safety and effectiveness of cantharidin-podophylotoxin-salicylic acid in the treatment of recalcitrant plantar warts. Dermatol Ther. 2016; 29:269-73.

-Kaçar N, Taşlı L, Korkmaz S, Ergin S, Erdoğan BŞ. Cantharidin-podophylotoxin-salicylic acid versus cryotherapy in the treatment of plantar warts: a randomized prospective study. J Eur Acad Dermatol Venereol. 2012; 26(7):889-93.

–Nguyen J, Korta DZ, Chapman L, Kelly KM. Laser Treatment of Nongenital Verrucae: A Systematic Review. JAMA Dermatol. 2016; 152:1025-34.

–Konicke K, Olasz E. Successful Treatment of Recalcitrant Plantar Warts with Bleomycin and Microneedling. Dermatol Surg. 2016; 42:1007-8.

–Park JY, Park BW, Cho EB, Park EJ, Kim KH, Kim KJ. Clinical Efficacy of Diphenylcyclopropenone Immunotherapy as Monotherapy for Multiple Viral Warts.J Cutan Med Surg. 2018; 22:285-289.

-Nofal A, Alakad R. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population. J Dermatolog Treat. 2020:1-5.

-Nofal A, Alakad R. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population. J Dermatolog Treat. 2022; 33(2):1042-1046.

-Marei A, Nofal A, Alakad R, Abdel-Hady A. Combined bivalent human papillomavirus vaccine and Candida antigen versus Candida antigen alone in the treatment of recalcitrant warts. J Cosmet Dermatol. 2020; 19(3):758-762.

-Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011; 61(4):250-81.

-Pihl C, Lerche CM, Andersen F, Bjerring P, Haedersdal M. Improving the efficacy of photodynamic therapy for actinic keratosis: A comprehensive review of pharmacological pretreatment strategies. Photodiagnosis Photodyn Ther. 2023; 43:103703.

-Lee CN, Hsu R, Chen H, Wong TW. Daylight Photodynamic Therapy: An Update. Molecules. 2020; 25(21):5195.

-Zhang W, Jin Z, Gao T, Fan L, Wang W, Zeng X, Qin L. Topical 5-aminolevulinic acid photodynamic therapy for recalcitrant facial flat warts. Photodiagnosis Photodyn Ther. 2024; 45:103934.

-Ding A, Li C, Zhang J. Topical 5-aminolevulinic acid photodynamic therapy in the treatment of verruca plana: Report of 6 cases. Photodiagnosis Photodyn Ther. 2021; 3:102438.

-Soenjoyo KR, Chua BWB, Wee LWY, Koh MJA, Ang SB. Treatment of cutaneous viral warts in children: A review. Dermatol Ther. 2020; 33(6):e14034.

-Thèves C, Crubézy E, Biagini P. History of Smallpox and Its Spread in Human Populations. Microbiol Spectr. 2016; 4(4). doi: 10.1128/microbiolspec.

-Shchelkunova GA, Shchelkunov SN. Smallpox, Monkeypox and Other Human Orthopoxvirus Infections. Viruses. 2022; 15(1):103.

-Li X, Zhao M, Li Y, Zhang A, Liu Y, Li J, Li D, Guo J, Ma L, Mu Q. Enhancing diagnostic accuracy in common human poxvirus infections during mpox outbreak: A dermoscopy review. Skin Res Technol. 2023; 29(10):e13489.

-Minhaj FS. Poxvirus Epidemiology. Methods Mol Biol. 2025; 2860:1-14.

-De Clercq E, Jiang Y, Li G. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf. Travel Med Infect Dis. 2023; 52:102528.

-Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci U S A. 2023; 120(8):e2220415120.

-Titanji BK, Hazra A, Zucker J. Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review. JAMA. 2024; 332(19):1652-1662.

-Lu J, Xing H, Wang C, Tang M, Wu C, Ye F, Yin L, Yang Y, Tan W, Shen L. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduct Target Ther. 2023; 8(1):458).

–Saguil A, Krebs L, Choe U. Mpox: Rapid Evidence Review. Am Fam Physician. 2023; 108(1):78-83.

-Soltani S, Shahbahrami R, Jahanabadi S, Siri G, Emadi MS, Zandi M. Possible role of CNS microRNAs in Human Mpox virus encephalitis-a mini-review. J Neurovirol. 2023; 29(2):135-140.

-Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, Smajlović S, Ćordić S, Rabaan AA, Alsuhaimi E. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. J Infect Public Health. 2023; 16(4):531-541.

-Jhancy M. Poxvirus Vaccines: Past, Present, and Future. Adv Exp Med Biol. 2024; 1451:273-287.

-Santacroce L, Magrone T. Molluscum Contagiosum Virus: Biology and Immune Response. Adv Exp Med Biol. 2024; 1451:151-170.

-Arora N, Wittmer A, Najmi M, Justus J, Hendrick S. An Atypical Presentation of Molluscum Contagiosum in a Newborn. Cureus. 2024; 16(7):e63932. doi: 10.7759/cureus.63932.

-Han H, Smythe C, Yousefian F, Berman B. Molluscum Contagiosum Virus Evasion of Immune Surveillance: A Review. J Drugs Dermatol. 2023; 22(2):182-189.

-Al Hamrashdi M, Sanchez Perez C, Haas DA, Vishwakarma J, Pichlmair A, Bowie AG, Brady G. Molluscum contagiosum virus protein MC089 inhibits interferon regulatory factor 3 activation. J Gen Virol. 2024; 105(8):002015.

-Basdag H, Rainer BM, Cohen BA. Molluscum contagiosum: to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States. Pediatr Dermatol. 2015; 32:353-7.

-Shisler JL. Immune evasion strategies of molluscum contagiosum virus. Adv Virus Res. 2015; 92:201-52.

-Han H, Smythe C, Yousefian F, Berman B. Molluscum Contagiosum Virus Evasion of Immune Surveillance: A Review. J Drugs Dermatol. 2023; 22(2):182-189.

-Zidan AA, Kaufman AR, Stagner AM, Jacobs DS, Dana R, Yin J. Primary Conjunctival Molluscum Contagiosum in a Patient With Ocular Graft-Versus-Host Disease. Cornea. 2024. doi: 10.1097/ICO.0000000000003699.

-Sin-Soler M, Lara A, Ribera M. Atypical Molluscum Contagiosum in a Psoriatic Patient on Biological Therapy. Actas Dermosifiliogr. 2024:S0001-7310(24)00778-6.

-Bertoli C, Longo C, Di Lernia V. Molluscum contagiosum under treatment with upadacitinib for atopic dermatitis. Int J Dermatol. 2024. doi: 10.1111/ijd.17494.

-Yunoki M, Fukuchi K, Fujiyama T, Ito T, Honda T. Resolution of Molluscum Contagiosum After Discontinuation of Topical Corticosteroids During Dupilumab Therapy for Atopic Dermatitis: A Case Report. Cureus. 2024; 16(8):e67391.

-Beutler BD, Cohen PR. Molluscum contagiosum of the eyelid: case report in a man receiving methotrexate and literature review of molluscum contagiosum in patients who are immunosuppressed secondary to methotrexate or HIV infection. Dermatol Online J. 2016; 22. pii: 13030/qt8vz669cj.

-Leung AKC, Barankin B, Hon KLE. Molluscum Contagiosum: An Update. Recent Pat Inflamm Allergy Drug Discov. 2017;11(1):22-31.

-Eichenfield L, Hebert A, Mancini A, Rosen T, Weiss J. Therapeutic Approaches and Special Considerations for Treating Molluscum Contagiosum. J Drugs Dermatol. 2021; 20(11):1185-1190.

-Guzman AK, Schairer DO, Garelik JL, Cohen SR. Safety and efficacy of topical cantharidin for the treatment of pediàtric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial. Int J Dermatol. 2018; 57:1001-1006.

-Teixidó C, Díez O, Marsal JR, Giner-Soriano M, Pera H, Martinez M, Galindo-Ortego G, Schoenenberger JA, Real J, Cruz I, Morros R. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum. Pediatr Dermatol. 2018; 35:336-342.

-Rajalingam K, Chen WS, Lin A. Analysis of pediatric outpatient visits uncovers disparities in molluscum contagiosum treatment across medical specialties in the United States. Dermatol Reports. 2023; 16(2):9851.

-Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL. Hand, Foot, and Mouth Disease: A Narrative Review. Recent Adv Inflamm Allergy Drug Discov. 2022;16(2):77-95.

-Guerra AM, Orille E, Waseem M. Hand, Foot, and Mouth Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.2023 Mar 4.

-Gomes S, Santos S, Ferreira Maia I, Verissimo R, Carvalho T. Hand-Foot-Mouth Disease in an Adult. Cureus. 2023; 15(1):e33670.

-Zhu P, Ji W, Li D, Li Z, Chen Y, Dai B, Han S, Chen S, Jin Y, Duan G. Current status of hand-foot-and-mouth disease. J Biomed Sci. 2023; 30(1):15.

-Ventarola D, Bordone L, Silverberg N. Update on hand-foot-and-mouth disease. Clin Dermatol. 2015; 33:340-6.

-Luo KW, Gao LD, Hu SX, Zhang H, Deng ZH, Huang W, Sun QL, Zhang F, Zhang SY, Chen Y. Hand, Foot, and Mouth Disease in Hunan Province, China, 2009-2014: Epidemiology and Death Risk Factors. PLoS One. 2016; 11:e0167269

-Han Y, Ji H, Shen W, Duan C, Cui T, Chen L, Hang H, Zhang Z, Sun H, Zhang X, Jin H. Disease burden in patients with severe hand, foot, and mouth disease in Jiangsu Province: a cross-sectional study. Hum Vaccin Immunother. 2022; 18(5):2049168.

-Mirand A, Peigue-Lafeuille H. Symptomatologie et évolution de la maladie «pieds-mains-bouche». Arch Pediatr. 2017; 24:1036-1046.

-Second J, Velter C, Calès S, Truchetet F, Lipsker D, Cribier B. Clinicopathologic analysis of atypical hand, foot, and mouth disease in adult patients. J Am Acad Dermatol. 2017; 76:722-729.

-Gonzalez G, Carr MJ, Kobayashi M, Hanaoka N, Fujimoto T. Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World. Int J Mol Sci. 2019; 20(20):5201.

-Justino MCA, da S Mesquita D, Souza MF, Farias FP, Dos S Alves JC, Ferreira JL, Lopes DP, Tavares FN. Atypical hand-foot-mouth disease in Belém, Amazon region, northern Brazil, with detection of coxsackievirus A6. J Clin Virol. 2020; 126:104307.

-Giachè S, Borchi B, Zammarchi L, Colao MG, Ciccone N, Sterrantino G, Rossolini GM, Bartoloni A, Trotta M. Hand, foot, and mouth disease in pregnancy: 7 years Tuscan experience and literature review. J Matern Fetal Neonatal Med. 2021; 34(9):1494-1500.

-Zhang X, Zhang Y, Li H, Liu L. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines. Int J Mol Sci. 2022; 24(1):169.

-Tricella C, Pagliani C, Quatrale A, Poretti G, Caiazzo R, Coppola C, Garcia Lorenzo M, Valentino MS, Giacomet V. Clinical Presentations of Parvovirus B19: A Case Series. Pediatr Infect Dis J. 2024. doi: 10.1097/INF.0000000000004541.

–Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007; 75:373-6.

-Vázquez-Osorio I, Mallo-García S, Rodríguez-Díaz E, Gonzalvo-Rodríguez P, Requena L. Parvovirus B19 infection presenting concurrently as papular-purpuric gloves-and-socks syndrome and bathing-trunk eruption. Clin Exp Dermatol. 2017; 42:58-60.

-Farcet MR, Karbiener M, Aberham C, Powers N, Aue D, Kreil TR. Parvovirus B19 rebound outbreak 2024 and implications for blood- and plasma-product safety. Transfusion. 2024 Oct 3. doi: 10.1111/trf.1803.

-Plümers R, Dreier J, Knabbe C, Vollmer T. Unexpected high incidence of parvovirus B19 nucleic acid detection in German blood donors in the winter/spring season 2023/2024. J Med Virol. 2024; 96(9):e29878.

-Solomon T, Powell A, Findeisen J. An Atypical Presentation of Parvovirus B19 Arthritis. J Rheumatol. 2024 Oct 1:jrheum.2024-0598.

-Kareem Ali M, Shia JS. Erythema nodosum manifestation of Parvovirus B19-associated reactive arthritis. J Infect Dev Ctries. 2024; 18(9):1435-1441.

-Arvia R, Stincarelli MA, Manaresi E, Gallinella G, Zakrzewska K. Parvovirus B19 in Rheumatic Diseases. Microorganisms. 2024; 12(8):1708.

-Jacquot R, Gerfaud-Valentin M, Mekki Y, Billaud G, Jamilloux Y, Sève P. Infection de l’adulte à Parvovirus. Rev Med Interne. 2022; 43(12):713-726.

-Means RT Jr. Pure red cell aplasia. Blood. 2016; 128:2504-2509.

-Algwaiz G, Alharbi A, Alsehaim K, Alahmari A, El Fakih R, Aljurf M. Hematologic Manifestations of Parvovirus B19 Infection. Hematol Oncol Stem Cell Ther. 2023; 16(4):316-322.

–Faddy HM, Gorman EC, Hoad VC, Frentiu FD, Tozer S, Flower RLP. Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia. BMC Infect Dis. 2018; 18:631.

-Kagan KO, Hoopmann M, Geipel A, Sonek J, Enders M. Prenatal parvovirus B19 infection. Arch Gynecol Obstet. 2024; 310(5):2363-2371.

-Dittmer FP, Guimarães CM, Peixoto AB, Pontes KFM, Bonasoni MP, Tonni G, Araujo Júnior E. Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge. J Pers Med. 2024; 14(2):139.

–Vadivel K, Mageshbabu R, Sankar S, Jain A, Perumal V, Srikanth P, Ranjan GA, Nair A, Simoes EAF, Nandagopal B, Sridharan G. Detection of parvovirus B19 in selected high-risk patient groups & their phylogenetic & selection analysis. Indian J Med Res. 2018; 147:391-399.

-Gigi CE, Anumba DOC. Parvovirus b19 infection in pregnancy – A review. Eur J Obstet Gynecol Reprod Biol. 2021; 264:358-362.

-Fölster-Holst R, Zawar V, Chuh A. Paravirale Exantheme. Hautarzt. 2017; 68:211-216.

-Chuh A, Zawar V, Sciallis GF, Kempf W, Lee A. Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies?. Infect Dis Rep. 2016; 8:6418.

-Leung AKC, Sergi CM, Lam JM, Leong KF. Gianotti-Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudescence and vaccine opposition. World J Pediatr. 2019; 15(6):521-527.

-Snowden J, Rice AS, Syed HA, O’Shea NE. Papular Acrodermatitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.2024 Mar 1.

-Stojkovic-Filipovic J, Skiljevic D, Brasanac D, Medenica L. Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 coinfection in a male adult: case report and review of the literature. G Ital Dermatol Venereol. 2016; 151:106-11.

-Drago F, Javor S, Ciccarese G, Parodi A. Gianotti-Crosti syndrome as presenting sign of cytomegalovirus infection: A case report and a critical appraisal of its possible cytomegalovirus etiology. J Clin Virol. 2016; 78:120-2.

-Dupont F, Aubry A, Lanoix JP, Demey B. Cytomegalovirus-Associated Gianotti-Crosti Syndrome in 28-Year-Old Immunocompetent Patient. Pathogens. 2022; 11(11):1338.

-Bürgler C, Weibel L, Schwieger-Briel A, Knöpfel N, Luchsinger I, Theiler M. Gianotti-Crosti syndrome-like reaction to molluscum contagiosum-Clinical characteristics and response to treatment. J Dtsch Dermatol Ges. 2021; 19(12):1746-1751.

-Daniel SS, Peterman C, Awasthi S. Updates on postinfectious skin rashes in pediatric dermatology. Curr Opin Pediatr. 2024; 36(4):431-435.

-Swali RN, Lee EB, Adams JL. Gianotti-crosti syndrome in the setting of recent coronavirus disease-19 infection. Pediatr Dermatol. 2021; 38(3):629-631.

-Kroeskop A, Lewis AB, Barril FA, Baribault KE. Gianotti-Crosti syndrome after H1N1-influenza vaccine. Pediatr Dermatol. 2011; 28:595-6.

-Retrouvey M, Koch LH, Williams JV. Gianotti-Crosti syndrome following childhood vaccinations. Pediatr Dermatol. 2013; 30:137-8.

-Leal SBC, Balconi SN, Cafrune FE. Gianotti-Crosti syndrome and yellow fever vaccine: unprecedented reaction. Int J Dermatol. 2021; 60(6):e227-e228.

-Oboli VN, Ebong IL, Tejada Amaro O, Regis JA, Waseem M. Gianotti-Crosti Syndrome: A Benign Dermatosis. Cureus. 2023; 15(6):e40328.

-Afonso A, Cachão J, Pinto Junior VL, Gouveia T. Gianotti-Crosti syndrome: a challenging exanthema. BMJ Case Rep. 2021; 14(4):e240747.

-Ricci G, Patrizi A, Neri I, Specchia F, Tosti G, Masi M. Gianotti-Crosti syndrome and allergic background. Acta Derm Venereol. 2003; 83:202-5.

-Fayos-Gregori R, Alonso-Fernández G, Mansilla-Polo M. Gianotti-Crosti syndrome mimicking scabies. Infection. 2024; 52(5):1707-1708.